The SPBC119.09c antibody targets the SPBC119.09c protein, a component of the serine palmitoyltransferase (SPT) enzyme complex in Schizosaccharomyces pombe (fission yeast). SPT catalyzes the first step in sphingolipid biosynthesis, converting serine and palmitoyl-CoA into 3-ketosphinganine . The SPBC119.09c protein contains four transmembrane domains, consistent with its localization in the endoplasmic reticulum (ER) membrane, where it interacts with other SPT subunits to regulate enzyme activity .
The SPBC119.09c protein is a 186-amino-acid polypeptide with predicted structural homology to the ORMDL family of ER-anchored membrane proteins . Its role in SPT activity was confirmed through immunoblot assays, which demonstrated its interaction with the LCB1-LCB2a heterodimer in yeast (Figure 2.4 and 2.5 in ). Functional studies revealed that SPBC119.09c modulates fatty acid specificity, favoring the production of stearoyl (C18:0)-CoA-derived sphingolipids .
| Characteristic | Value |
|---|---|
| Amino acid length | 186 |
| Transmembrane domains | 4 |
| Molecular weight | ~21 kDa |
| ER localization | Confirmed via immunoblot |
The SPBC119.09c antibody was developed using recombinant protein purified from yeast . Polyclonal antibodies were generated in rabbits immunized with the purified antigen . Validation included:
Western blotting: Detected a ~21 kDa band corresponding to SPBC119.09c in yeast lysates .
Immunoprecipitation: Co-purified with LCB1-LCB2a, confirming complex formation .
Subcellular localization: Confocal microscopy showed ER-specific staining .
The antibody enables:
Enzyme activity assays: Quantified SPT activity by detecting substrate-binding interactions .
Protein interaction studies: Identified SPBC119.09c’s role in SPT complex assembly .
Sphingolipid profiling: Linked SPBC119.09c expression to C18-LCB species accumulation .
Fatty acid specificity: SPBC119.09c biases SPT toward stearoyl-CoA, altering sphingolipid composition .
Conservation: Homologs exist in plants (Arabidopsis), Drosophila, and vertebrates, suggesting evolutionary conservation .
Disease relevance: Dysregulation of sphingolipid metabolism is implicated in neurodegenerative disorders, making SPBC119.09c a potential therapeutic target .
KEGG: spo:SPBC119.09c
STRING: 4896.SPBC119.09c.1
SPBC119.09c is a gene in S. pombe that encodes a predicted ORMDL family protein . ORMDL proteins are conserved transmembrane proteins of the endoplasmic reticulum involved in sphingolipid homeostasis and stress responses. Studying SPBC119.09c provides insights into fundamental cellular processes, including membrane biology and cellular stress responses. Antibodies against this protein enable researchers to investigate its expression, localization, interactions, and functional roles in various cellular contexts.
Researchers typically use polyclonal or monoclonal antibodies targeting different epitopes of the SPBC119.09c protein. Polyclonal antibodies offer high sensitivity by recognizing multiple epitopes, while monoclonal antibodies provide higher specificity by targeting a single epitope. For immunoprecipitation experiments, anti-FLAG or anti-HA antibodies are frequently used with tagged versions of SPBC119.09c, as demonstrated in protocols using protein G beads coated with anti-FLAG-antibody for immunoprecipitation .
Antibody validation is crucial to ensure reliable experimental results. Methods to validate SPBC119.09c antibodies include:
Western blotting with positive controls (SPBC119.09c-expressing cells) and negative controls (knockout or knockdown cells)
Immunoprecipitation followed by mass spectrometry to confirm target capture
Testing cross-reactivity against related ORMDL family proteins
Performing peptide competition assays
Using different antibodies targeting different epitopes of SPBC119.09c to confirm consistent results
Validation protocols should include protein extraction under denaturing conditions, determination of protein concentration, and SDS-PAGE protein electrophoresis as outlined in standard Western blot detection methods .
For successful immunoprecipitation of SPBC119.09c, consider these methodological approaches:
Cell lysate preparation: Collect cells and lyse them in appropriate lysis buffer with protease inhibitors. For S. pombe, bead beating is an effective lysis method .
Antibody binding: Add protein G beads coated with anti-FLAG-antibody (if using FLAG-tagged SPBC119.09c) to the cell lysate and incubate for 1 hour at 4°C with rotation .
Washing: After incubation, wash the beads thoroughly to remove non-specific interactions.
Elution: Elute the bound proteins using specific methods, such as using 3×FLAG peptide for FLAG-tagged proteins .
Analysis: Analyze the immunoprecipitated proteins by Western blot or mass spectrometry.
For TAP-tag purification, a sequential purification approach can be employed, using FLAG-antibody followed by HA magnetic beads as described in the literature for other proteins .
| Detection Aspect | Native SPBC119.09c | Tagged SPBC119.09c |
|---|---|---|
| Antibody specificity | Requires highly specific antibodies against the native protein | Can use well-characterized tag antibodies (e.g., anti-FLAG, anti-HA) |
| Signal strength | Often weaker due to native expression levels | Can be stronger, especially with overexpression systems |
| Background issues | Higher risk of cross-reactivity | Lower background when using validated tag antibodies |
| Functional impact | No impact on protein function | Tag may affect protein function or localization |
| Validation method | Western blot against knockout controls | Western blot comparing tagged vs. untagged strains |
For native SPBC119.09c detection, optimization of antibody concentration and incubation conditions is critical. For tagged versions, researchers commonly use expression systems like the nmt1 promoter with thiamine regulation, as seen in protocols for other S. pombe proteins .
SPBC119.09c antibodies are valuable tools for investigating protein-protein interactions through several approaches:
Co-immunoprecipitation (Co-IP): Similar to the protocol described for other proteins, cells expressing tagged SPBC119.09c can be lysed and subjected to immunoprecipitation using magnetic beads (such as uMACS HA magnetic beads). After washing, eluted proteins can be analyzed by Western blotting to identify interacting partners .
Proximity-based labeling: By fusing SPBC119.09c to enzymes like BioID or APEX2, researchers can identify proximal proteins in living cells.
Chromatin immunoprecipitation (ChIP): If SPBC119.09c is involved in chromatin-related functions, ChIP can be performed using protocols similar to those described for H3K9me antibody immunoprecipitation .
Immunofluorescence co-localization: Antibodies can be used to determine if SPBC119.09c co-localizes with other proteins of interest, providing spatial information about potential interactions.
Based on research with related proteins, SPBC119.09c may interact with various chromatin remodeling complexes. Studies of other nuclear proteins in S. pombe have shown interactions with:
To investigate these interactions specifically for SPBC119.09c, researchers should conduct immunoprecipitation followed by mass spectrometry analysis. The protocol could follow methods described for other proteins: culturing cells expressing tagged SPBC119.09c, cell lysis, immunoprecipitation with appropriate antibodies, sample preparation for MS, and comprehensive bioinformatic analysis of MS results .
While direct evidence for SPBC119.09c's role in nuclear envelope dynamics is not provided in the search results, research on other proteins suggests methodological approaches to investigate this question:
Live-cell imaging using antibodies or fluorescently tagged SPBC119.09c to track its localization during cell cycle progression.
Analyses of nuclear morphology in SPBC119.09c mutants, possibly using tagged inner-NE and NPC components (like Man1-tomato and Nup60-mCherry) .
Investigation of SPBC119.09c's interactions with nuclear pore complex components, as suggested by the genetic interactions between telomere regulation and nuclear pore components Nup60 and Nup132 .
Cold-sensitivity assays, as nuclear envelope properties are affected by temperature, with increased rigidity at lower temperatures (19°C) compared to higher temperatures (32°C) .
These approaches would help determine if SPBC119.09c, like some other ER/nuclear envelope proteins, plays a role in nuclear membrane organization or dynamics.
Post-translational modifications (PTMs) of SPBC119.09c can significantly impact antibody recognition. Key considerations include:
| Modification Type | Potential Impact | Experimental Approach |
|---|---|---|
| Phosphorylation | May mask or create antibody epitopes | Compare recognition before and after phosphatase treatment |
| Glycosylation | Can block antibody access to protein epitopes | Use deglycosylation enzymes before antibody application |
| Ubiquitination | May alter protein conformation | Use antibodies that specifically recognize modified/unmodified forms |
| Proteolytic processing | Antibody may not recognize cleaved fragments | Use antibodies targeting different regions of the protein |
To address these challenges, researchers should:
Use multiple antibodies targeting different epitopes
Consider cell treatment conditions that might affect PTMs
Perform Western blots under different conditions to verify consistent recognition
Validate antibody recognition patterns with mass spectrometry analysis
High background in Western blots with SPBC119.09c antibodies can result from several factors:
Non-specific antibody binding: Optimize blocking conditions using different blockers (BSA, non-fat milk, or commercial alternatives) at various concentrations and incubation times.
Insufficient washing: Increase the number and duration of wash steps using appropriate buffers.
Antibody concentration: Titrate the primary antibody to determine optimal concentration; excess antibody often leads to higher background.
Cross-reactivity: The antibody may recognize proteins similar to SPBC119.09c. Perform peptide competition assays to verify specificity.
Sample preparation issues: Ensure proper protein extraction under denaturing conditions and accurate protein concentration determination as outlined in standard protocols .
For Western blots, follow the general procedure of protein extraction under denaturing conditions, determination of protein concentration, SDS-PAGE protein electrophoresis, and appropriate detection methods .
To enhance signal-to-noise ratio in immunoprecipitation of SPBC119.09c:
Pre-clear lysates: Incubate cell lysates with beads alone before adding antibody to remove proteins that bind non-specifically to beads.
Optimize salt concentration: Adjust salt concentration in wash buffers to reduce non-specific interactions while maintaining specific binding.
Use tandem purification: Consider a two-step purification approach like the TAP-tag method described, where FLAG-antibody purification is followed by HA magnetic bead purification .
Control bead-to-lysate ratio: Too many beads can increase non-specific binding; optimize this ratio empirically.
Include appropriate controls: Always include a negative control (e.g., cells expressing the tag alone) for comparison .
Consider crosslinking: In some cases, gentle crosslinking can stabilize interactions while allowing more stringent washing.
For accurate quantification of SPBC119.09c across different conditions:
For reliable quantification:
Include appropriate loading controls and normalization methods
Use technical and biological replicates
Consider implementing internal standards for absolute quantification
Validate results using complementary methods (e.g., confirm Western blot findings with mass spectrometry)
Emerging antibody technologies offer new opportunities for SPBC119.09c research:
Nanobodies: Single-domain antibodies derived from camelids offer smaller size for accessing restricted epitopes and superior performance in live-cell imaging.
Intrabodies: Antibodies engineered to function within living cells can track SPBC119.09c in real-time and potentially disrupt specific interactions.
Optogenetic antibody tools: Light-activatable antibody systems allow temporal control of protein inhibition or visualization.
Mass cytometry (CyTOF): Metal-conjugated antibodies enable highly multiplexed analysis of SPBC119.09c in relation to dozens of other cellular markers simultaneously.
Proximity labeling: Antibody-enzyme fusions that catalyze labeling of proximal proteins can map the SPBC119.09c interactome with spatial and temporal resolution.
These technologies could help resolve outstanding questions about SPBC119.09c's dynamic interactions, regulatory mechanisms, and functions in different cellular compartments.
When designing cross-species studies of SPBC119.09c:
Sequence homology analysis: Determine the degree of conservation between SPBC119.09c and its orthologs in other species to guide epitope selection for antibodies.
Expression system compatibility: Consider species-specific promoters and expression levels when creating tagged constructs for comparative studies.
Antibody cross-reactivity testing: Validate whether antibodies against S. pombe SPBC119.09c recognize orthologs in other species, or whether species-specific antibodies are required.
Control for cellular context differences: ORMDL family proteins may have divergent functions or interaction partners across species, requiring careful interpretation of results.
Complementation assays: Test functional conservation by expressing SPBC119.09c orthologs in S. pombe deletion mutants and vice versa.
Researchers should standardize experimental conditions as much as possible while accounting for species-specific differences in optimal growth conditions, cell wall composition, and genetic manipulation techniques.